TickerFactsScreenerDevelopers

Iterum Therapeutics plc (ITRMF) — Operating Income

Annual figures by fiscal year, from SEC filings.

2016: -$13.36M2017: -$29.45M2018: -$76.56M2019: -$102.02M2020: -$32.13M2021: -$24.54M2022: -$30.38M2023: -$47.47M2024: -$18.70M-$18.70M
2016Operating Income (USD)2024
Fiscal YearOperating IncomeChange YoY
2024-$18.70M+60.6%
2023-$47.47M-56.2%
2022-$30.38M-23.8%
2021-$24.54M+23.6%
2020-$32.13M+68.5%
2019-$102.02M-33.3%
2018-$76.56M-159.9%
2017-$29.45M-120.5%
2016-$13.36M—